News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
146 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17891)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Business
Immunocore CEO Steps Down, Effective Immediately
Dr Forster informed the Board of his decision earlier this week and will be replaced, in an interim capacity, by Chief Commercial Officer Andrew Hotchkiss.
February 8, 2018
·
3 min read
Business
OraSure Announces Record 2017 Fourth Quarter and Full-Year Financial Results
Consolidated net revenues for the fourth quarter of 2017 were $52.0 million, a 47% increase from the fourth quarter of 2016.
February 8, 2018
·
17 min read
Drug Development
ArmaGen’s AGT-181 Demonstrates Neurocognitive Benefit in Children With Severe MPS I
On a somatic level, AGT-181 stabilized urinary glycosaminoglycans, reduced liver and spleen volume including in patients previously exposed to laronidase, and further improved shoulder range of motion.
February 8, 2018
·
7 min read
Biotech Beach
GenomeDx Biosciences’ Decipher Tests and Decipher GRID to be Featured in Multiple Presentations at 2018 Genitourinary Cancers Symposium
The 2018 GU Cancers Symposium is the premier scientific and educational meeting .
February 8, 2018
·
6 min read
Business
Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors
Newron today announced that Bo Jesper Hansen has informed the Board of Directors of his intention to step down as a Non-Executive Director, effective from this year’s Annual Shareholders Assembly taking place on March 27, 2018.
February 8, 2018
·
5 min read
Biotech Beach
MediciNova Announces Proposed Underwritten Public Offering of Common Stock
The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
February 8, 2018
·
6 min read
Pixium Vision Announces its 2017 Annual Results and Provides Business Update
Pixium Vision announced today its 2017 financial results.
February 8, 2018
·
9 min read
Business
Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%
Total revenue was $4.8 million for the third quarter as compared to $3.4 million for the same period last year.
February 8, 2018
·
15 min read
Biotech Bay
Personalis Launches ImmunogenomicsID for Multidimensional Immuno-Oncology Biomarker Analysis
Personalis today announced the launch of ImmunogenomicsID, a new component of the ACE ImmunoID Platform.
February 8, 2018
·
2 min read
Business
Aytu BioScience Provides Fiscal Second Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET
Aytu BioScience today provided an overview of its business, including the Company’s operational and financial results for its fiscal second quarter ended December 31, 2017.
February 8, 2018
·
20 min read
Previous
14 of 15
Next